Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2015 /
'Liquid biopsy' may help earlier detection of lung cancer treatment resistance

18th - 22nd Apr 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 13.05.15
Views: 2165

Dr Jonas Nilsson - Umeå University, Umeå, Sweden

Dr Nilsson talks to ecancertv at AACR 2015 about the development of a blood test which regularly monitors for the presence of the rearrangement of the EML4-ALK gene fusion in patients with non-small cell lung cancer (NSCLC), helping clinicians predict the outcome of treatment with crizotinib.

Read the news story for more.



Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation